Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic graft rejection

H Azuma1, N L Tilney

  • 1Surgical Research Laboratory, Harvard Medical School, Boston, Massachusetts.

Current Opinion in Immunology
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

Chronic rejection, a major cause of organ graft failure, involves both immune and non-immune injury to endothelial cells. Addressing non-immune factors like ischemia is crucial alongside immunosuppression for better graft survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In response to "Obstetric anesthesia in Japan: an existential crisis in need of an intervention".

International journal of obstetric anesthesia·2025
Same author

Comprehensive validation of early diagnostic algorithms for myocardial infarction in the emergency department.

QJM : monthly journal of the Association of Physicians·2023
Same author

Effect of Systematic Conversion to Generic Mycophenolate Mofetil (MMF) in Kidney Transplantation: A Single-Center Clinical Experience from Japan.

Transplantation proceedings·2018
Same author

Application of Perfusate With Human-Derived Oxygen Carrier Solution Under Subnormothermic Machine Perfusion for Donation After Cardiac Death Liver Grafts in Pigs.

Transplantation proceedings·2018
Same author

Safety of Elderly Living Kidney Donors: 2 Cases of Donors Older Than 80 Years: A Case Report.

Transplantation proceedings·2018
Same author

Dual Gas Treatment With Hydrogen and Carbon Monoxide Attenuates Oxidative Stress and Protects From Renal Ischemia-Reperfusion Injury.

Transplantation proceedings·2018
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

Area of Science:

  • Transplantation immunology
  • Organ graft research
  • Vascular biology

Background:

  • Chronic rejection is the primary cause of long-term organ graft loss.
  • The exact causes of chronic rejection are not fully understood.
  • Early graft injury, from factors like ischemia/reperfusion or acute rejection, is implicated.

Purpose of the Study:

  • To explore the multifactorial etiology of chronic organ graft rejection.
  • To highlight the roles of immune and non-immune factors in graft injury.
  • To emphasize the need for comprehensive strategies against chronic rejection.

Main Methods:

  • Review of existing literature on chronic rejection mechanisms.
  • Analysis of the roles of endothelial cell injury, macrophages, and cytokine-adhesion molecule cascades.

Related Experiment Videos

  • Consideration of both alloantigen-dependent and independent pathways.

    • Main Results:

    • Both alloantigen-independent (e.g., ischemia, reperfusion) and alloantigen-dependent (e.g., acute rejection) events contribute to early graft injury.
    • Macrophages, growth factors, and adhesion molecules are key players in the cytokine-adhesion molecule cascade.
    • Current immunosuppressants (e.g., RS61443, rapamycin) may address immune components but not initial non-immune injury.

    Conclusions:

    • Effective management of chronic rejection requires addressing both immune and non-immune injury pathways.
    • Mitigating non-immune risk factors, such as initial ischemia, is essential for long-term graft survival.
    • Future strategies must integrate immunosuppression with interventions targeting early non-immune damage.